In an era where public awareness of food safety and mental health is at an all-time high, biogenic amines (BAs) are emerging as a key topic of concern and curiosity. These small but powerful molecules—ranging from histamine and tyramine to serotonin and dopamine—not only affect the quality of our food but also play a pivotal role in our brain chemistry, gut microbiota, and overall health.
This article explores the growing importance of biogenic amines from multiple perspectives: consumer safety, scientific discovery, and technological innovation. We'll also examine how analytical solutions like Biogenic Amine Analysis Services are enabling researchers and industries to monitor and control these compounds with unprecedented precision.
Contents What Are Biogenic Amines? Why Are Biogenic Amines a Growing Concern? The Gut-Brain Axis: A Microbial Perspective Analytical Challenges in Biogenic Amine Detection Case Study: Supporting Drug Discovery in Depression Research Applications Across Sectors: Bridging Molecules, Biology, and Innovation |
What Are Biogenic Amines?
Biogenic amines are low-molecular-weight organic bases formed primarily through the enzymatic decarboxylation of amino acids or through microbial activity. They are naturally present in a variety of foods, especially:
- Fermented products (cheese, soy sauce, sauerkraut)
- Protein-rich perishables (fish, cured meats)
- Alcoholic beverages (wine, beer)
Common BAs include:
Biogenic Amine | Precursor Amino Acid | Typical Source |
Histamine | Histidine | Fish, wine |
Tyramine | Tyrosine | Cheese, beer |
Putrescine | Ornithine | Spoiled meat |
Cadaverine | Lysine | Aged meat |
Dopamine | Tyrosine | Endogenous |
Serotonin | Tryptophan | Endogenous |
While some of these amines are crucial neurotransmitters in the human body, their accumulation in food can pose serious health risks—ranging from migraines and hypertension to food poisoning.
Why Are Biogenic Amines a Growing Concern?
Food Safety: A Consumer Health Issue
Several global food alerts in 2024–2025 have placed biogenic amines at the center of food safety discussions. One case involved histamine intoxication in Europe from improperly stored canned tuna, where histamine levels exceeded 200 mg/kg—the EU safety threshold. Symptoms reported included rash, nausea, and hypotension.
This has spurred regulatory bodies such as the FDA and EFSA to strengthen surveillance of BA levels in high-risk foods. For producers, this means increased demand for reliable analytical solutions to:
- Monitor BA content throughout shelf life
- Validate fermentation processes
- Ensure export compliance with international limits
At Creative Proteomics, our Biogenic Amine Analysis Service uses ultra-sensitive LC-MS/MS technology to quantify trace-level amines in food samples, ensuring compliance with global standards.
Mental Health and Neurochemistry
Biogenic amines such as dopamine, norepinephrine, and serotonin are essential in the regulation of mood, attention, motivation, and cognitive behavior. Disruptions in their biosynthesis, degradation, or receptor signaling have been implicated in:
- Depression
- Anxiety disorders
- Schizophrenia
- Neurodegenerative diseases like Parkinson's
A 2025 Nature Mental Health study demonstrated how individuals with major depressive disorder exhibited altered levels of serotonin and its metabolites in cerebrospinal fluid. These findings strengthen the need for accurate, targeted quantification of neurotransmitters in both animal models and clinical studies.
Our Biogenic Amine Analysis supports neurobiology labs with reproducible, high-throughput profiling of monoamine neurotransmitters, enabling robust correlation studies between biochemistry and behavior.
The Gut-Brain Axis: A Microbial Perspective
One of the most exciting scientific developments in recent years is the recognition of the gut-brain axis—the bidirectional communication network between the gastrointestinal tract and the central nervous system—and how the gut microbiota influences host physiology through the production and degradation of biogenic amines.
Key highlights include:
- Enterochromaffin cells in the gut produce over 90% of the body's serotonin, and this process is highly modulated by microbial metabolites such as short-chain fatty acids and tryptophan catabolites.
- Certain gut-resident bacteria—including Lactobacillus, Enterococcus, and Clostridium—can decarboxylate amino acids to produce tyramine, tryptamine, and putrescine. These microbially derived amines influence not only gut motility and inflammation but also have systemic effects on mood, behavior, and cognition.
- Biogenic amines can act as neuromodulators by signaling through host receptors like TAARs (trace amine-associated receptors) and GPCRs, directly affecting neural circuits involved in stress and reward.
- The presence or absence of microbial decarboxylase genes is being explored as a biomarker of gut dysbiosis, linked to conditions such as IBS, autism spectrum disorder, and even Parkinson's disease.
A 2024 Cell Host & Microbe paper reported that microbiome-mediated modulation of dopamine levels in mice influenced stress resilience, learning behavior, and social interaction. These findings underscore the value of multi-omics integration, combining microbiome sequencing, transcriptomics, and quantitative BA profiling.
For microbiome researchers, our LC-MS/MS BA platform offers quantitative metabolomics data to enrich multi-omics models of gut-brain communication.
Analytical Challenges in Biogenic Amine Detection
Analyzing biogenic amines is analytically demanding due to several biochemical and methodological hurdles:
- Low endogenous concentrations in complex biological matrices (e.g., plasma, cerebrospinal fluid, fermented food) require highly sensitive instrumentation. Many BAs exist at nanomolar or even picomolar levels, especially in clinical samples.
- Their high polarity and structural similarity complicate chromatographic separation, while some BAs (like serotonin or putrescine) are chemically unstable and prone to degradation during extraction or storage.
- Derivatization is often required to improve chromatographic behavior and detection sensitivity, particularly when using HPLC-UV or fluorescence detection. However, derivatization must be carefully optimized to avoid incomplete reactions, side-products, or losses.
- Matrix effects such as ion suppression or enhancement are common in LC-MS/MS analyses, especially in lipid-rich or protein-heavy samples. These effects can severely impact quantification unless appropriate internal standards and clean-up steps (e.g., solid-phase extraction, protein precipitation) are employed.
- Method development must also consider key validation parameters:
• Limit of Detection (LOD) and Limit of Quantification (LOQ)
• Linearity, accuracy, and precision
• Recovery rates and reproducibility across runs
• Stability during sample processing and storage
These challenges make platform selection critical. Compared to traditional methods like HPLC-UV or fluorometric assays, LC-MS/MS offers superior specificity, lower detection limits, and multiplex capability—enabling simultaneous quantification of over 20 amines in a single run.
✔️ Key Features of Our Biogenic Amine Analysis Service:
- Absolute quantification using stable isotope-labeled internal standards to correct for matrix effects
- Coverage of over 20 endogenous and exogenous BAs, including trace polyamines and monoamines
- Flexible sample types: plasma, cerebrospinal fluid, brain tissue, fermented foods, cell culture media
- Custom panel development for novel or specialized targets in food science, neuroscience, and microbiome studies
Looking ahead, novel technologies such as nano-LC, capillary electrophoresis-MS, and biosensor arrays are being explored to further enhance sensitivity, miniaturization, and field deployability.
Case Study: Supporting Drug Discovery in Depression Research
Title: LC-MS/MS-Based Quantification of Neurotransmitters in a Mouse Model of Depression
DOI: https://doi.org/10.1016/j.jchromb.2019.02.021
Objective:
To develop a rapid, sensitive, and specific LC-MS/MS method for the simultaneous determination of tryptophan (Trp), its metabolites, and related neurotransmitters in mice serum and brain tissues, and to apply this method to analyze biological samples from control and chronic mild stress (CMS)-induced depression mice.
Methodology:
The study established an LC-MS/MS method capable of simultaneously quantifying multiple analytes, including Trp, l-kynurenine (Kyn), kynurenic acid (Kyna), 3-hydroxykynurenine (3-HK), 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), norepinephrine (NE), l-glutamic acid (Glu), γ-aminobutyric acid (GABA), and acetylcholine (ACh) in mice serum and brain tissues. The method utilized a Restek Ultra Aqueous C18 column with gradient elution, achieving chromatographic separation within 8 minutes. Mass spectrometric detection was performed using multiple reaction monitoring with electrospray ionization in positive mode.
Findings:
Application of the method to biological samples from control and CMS-induced depression mice revealed that the CMS model led to significant alterations in neurotransmitter levels. Specifically, Kyn and 3-HK pathways were enhanced, while levels of Trp, Kyna, 5-HIAA, Glu, GABA, and ACh were significantly reduced. Notably, changes in 5-HT and NE levels were not uniform between the periphery and the brain.
Significance:
This study provided a robust analytical tool for the comprehensive profiling of neurotransmitters and their metabolites, facilitating a deeper understanding of the biochemical alterations associated with depression. The method's high sensitivity and specificity make it valuable for monitoring disease states and evaluating therapeutic interventions in neuropsychiatric research.

Representative LC-MS/MS chromatograms of a standard sample containing tryptophan (Trp), kynurenine (Kyn), kynurenic acid (Kyna), 3-hydroxykynurenine (3-HK), 5-HT, 5-HIAA, dopamine (DA), norepinephrine (NE), glutamic acid (Glu), GABA, acetylcholine (ACh), and internal standard. All compounds show clear peaks at expected concentrations, demonstrating method sensitivity and separation efficiency.
Applications Across Sectors: Bridging Molecules, Biology, and Innovation
Biogenic amines (BAs) are now recognized as important molecular indicators and mediators in various biological and technological contexts. Their analysis supports research and development across a range of sectors:
Sector | Research & Development Applications |
Food Science & Fermentation | - Monitoring amine levels in fermented foods (e.g., cheese, soy sauce, cured meats) - Assessing the influence of raw materials, microbes, and processing on BA formation - Studying spoilage markers in storage and packaging research |
Neurobiology & Behavior Studies | - Quantifying monoamines like dopamine and serotonin in brain regions - Supporting studies on cognitive performance, attention, and stress responses - Providing biochemical endpoints in behavioral neuroscience |
Microbiome Research | - Measuring BAs produced by gut microbes to explore microbial-host interactions - Linking microbial metabolism to host signaling pathways - Contributing to multi-omics studies of microbial function |
Nutrition & Life Sciences | - Studying naturally occurring polyamines like spermidine in relation to cellular function - Exploring the relationship between diet composition and BA profiles - Investigating BAs as dietary biomarkers in population studies |
Bioprocessing & Ingredient Innovation | - Screening microbial strains for BA production profiles in probiotic or fermentation research - Supporting formulation of functional ingredients with specific amine characteristics - Monitoring bioactive compounds in product development pipelines |
Reference
Gholizadeh-Hashjin, Aiesheh, et al. "Direct quantitative detection of host cell residual DNA in recombinant Filgrastim by qPCR." Analytical Biochemistry 629 (2021): 114296. https://doi.org/10.1016/j.ab.2021.114296